Severe cough after taking Vemurafenib

Vemurafenib (Vemurafenib) is marketed to treat melanoma (a type of skin cancer) that has spread or cannot be removed by surgery. It is only used if the melanoma cells have the BRAF V600E mutation, and doctors will use a special test to look for this mutation. Vemurafenib is also used to treat Erdheim-Chester disease (ECD), a blood cancer that affects the body's tissues and organs. It is used only if the cancer cells have the BRAF V600 mutation. Vemurafenib is an anti-cancer drug.

The most common side effects of vemurafenib include joint pain, fatigue, rash, photosensitivity reactions, nausea and vomiting, alopecia, diarrhea, headache, pruritus, cutaneous papilloma, and hyperkeratosis. Severe cough may not be one of the common adverse reactions of vemurafenib. Therefore, if the patient's cough worsens while taking vemurafenib, it is recommended to seek medical treatment in time and inform the doctor of the situation. Testing and treatment may be needed to determine the cause of the cough and take appropriate measures. At the same time, if you have symptoms such as difficulty breathing, shortness of breath, chest pain, etc., you should seek medical attention immediately.

Vemurafenib The original drug has been launched in China and has entered the scope of medical insurance. The price of 240mg*56 tablets per box may be around 7,000 yuan, which is very expensive. The Turkish version of Vemurafenib Original drug listed overseas, specifications240mg*56 tablets, may cost more than 2,000 yuan per box (the price may fluctuate due to exchange rates), which is relatively cheap. There is currently no generic version of Vemurafenib on the market. For more drug information and specific prices, please consult a medical consultant.